Search Results | OpenEmory

Start Over Keyword SALVAGE CHEMOTHERAPY

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Authors:Edmund Waller, Emory University

Date:2013

Publisher:American Society of Clinical Oncology

Publication Version:Final Published Version